German pharmaceutical company Bio NTech , which has been working on a Covid 19 vaccine with US Pharmaceutical giant Pfizer , will file paperwork for the emergency use of its vaccine in the United States on Friday , the company CEO , Uğur Şahin told CNN in an interview on Wednesday . 
Earlier today , Pfizer announced that a final analysis of the Phase 3 trial of its coronavirus vaccine shows it was 95 % effective in preventing infections , even in older adults , and caused no serious safety concerns . 
CNN 's Sanjay Gupta explains Pfizer 's 95 % effectiveness rate : 
